A provided
medicine for treating chronic obstructive
pulmonary disease at a
stable phase comprises the bulk drugs: radix
codonopsis, Chinese yam, radix asteris,
semen lepidii, radix et caulis acanthopanacis senticosi, herba epimedii, pubescent holly root, rhizoma cynanchi stauntonii, herba Inulae, herba schizonepetae, radix angelicae dahuricae, cacumen tamaricis, fructus corni, radix scrophulariae,
thallus laminariae, caulis bambusae in taenia, caulis spatholobi, Chinese
caterpillar fungus,
semen sesami nigrum,
semen euryales,
radix rehmanniae preparata, littleleaf Indianmulberry
herb, semen armeniacae amarum, rhizoma pinelliae preparatum, herba cistanches,
ziziphus jujube,
pericarpium citri reticulatae, fructus toosendan, calyx kaki, stigma croci, lignum sappan, leucas mollissima and
ligusticum wallichii. The
medicine is capable of improving the symptoms of cough,
asthma and
phlegm of a patient attacked by chronic obstructive
pulmonary disease, improving the body
immunity of the patient, promoting restoration and regeneration of
respiratory mucosa damaged
epithelium, thoroughly preventing
attack or reducing acute
attack frequency, mitigating
attack symptoms and
respiratory muscle fatigue and dystrophia state, alleviating progressive decrease of pulmonary functions, controlling developing of
disease state, improving
life quality and reducing morality rate.